HALO COLLECTIVE (HCANF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 18 168 sessions, September 1, 2023 to September 4, 2024
- Largest daily move
- +4350% close of October 19, 2023
- 1-year change
- -98.5% closing prices, September 1, 2023 to September 4, 2024
- 1-month change
- +0% closing prices, August 2, 2024 to September 4, 2024
Company Description
HALO COLLECTIVE (OTC: HCANF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $15.1K.
HCANF has declined 98.5% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for HCANF, including price data, latest news, and short interest trends.
Stock Performance
HALO COLLECTIVE (HCANF) closed at $0.0001 on September 4, 2024. Over the past 12 months, the price has lost 98.5%.
HCANF Metrics & Rankings
Price returns through September 4, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HALO COLLECTIVE has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, acquisition, management. View all HCANF news →
SEC Filings
Short Interest History
Short interest in HALO COLLECTIVE (HCANF) currently stands at 1 shares.
Days to Cover History
Days to cover for HALO COLLECTIVE (HCANF) currently stands at 1000.0 days, up 99899% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
HCANF Company Profile & Sector Positioning
HALO COLLECTIVE (HCANF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HCANF often look at related companies in the same sector, including ITEM 9 LABS CORP (INLB), VERITAS FARMS INC (VFRM), ONASSIS HOLDINGS CORP (ONSS), BLOOMIOS INC (BLMS), and AVIVAGEN INC (VIVXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HCANF's relative position within its industry.